Claims (10)
一種壁癌生成抑制材料,其為包含改質蒙脫土及天然纖維素之混和物。A wall cancer production inhibiting material comprising a mixture of modified montmorillonite and natural cellulose.
如申請專利範圍第1項所述之壁癌生成抑制材料,該改質蒙脫土為比未改質蒙脫土具有相對較高之層間距之蒙脫土。The wall cancer production inhibiting material according to claim 1, wherein the modified montmorillonite is a montmorillonite having a relatively high layer spacing than the unmodified montmorillonite.
如申請專利範圍第1或2項所述之壁癌生成抑制材料,該天然纖維素之含量比例介於為90~10wt%;該蒙脫土之比例範圍為10~90wt%。The wall cancer production inhibiting material according to claim 1 or 2, wherein the content ratio of the natural cellulose is between 90 and 10% by weight; and the ratio of the montmorillonite is from 10 to 90% by weight.
如申請專利範圍第1或2項所述之壁癌生成抑制材料,該天然纖維素係選自於由纖維素、甲基纖維素、乙基纖維素、醋酸纖維素、氫氧乙基纖維素及其混和物所組成的群組。The wall cancer production inhibiting material according to claim 1 or 2, wherein the natural cellulose is selected from the group consisting of cellulose, methyl cellulose, ethyl cellulose, cellulose acetate, and hydroxyethyl cellulose. a group of its blends.
如申請專利範圍第4項所述之壁癌生成抑制材料,該改質蒙脫土係為與一有機改質劑聚合而產生層間距擴張的改質蒙脫土。The wall cancer production inhibiting material according to claim 4, wherein the modified montmorillonite is a modified montmorillonite which is polymerized with an organic modifier to cause a layer spacing expansion.
如申請專利範圍第5項所述之壁癌生成抑制材料,該改質蒙脫土之層間距為40A±10A。The wall cancer production inhibiting material according to claim 5, wherein the layer spacing of the modified montmorillonite is 40A±10A.
一種壁癌生成抑制材料之製造方法,其製程步驟包含:以物理或化學方法將一蒙脫土改質以產生具有相對較寬層間距之一改質蒙脫土;取一天然纖維素以一特定比例與該改質蒙脫土於水相環境下混合或聚合。A method for producing a wall cancer production inhibiting material, the process step comprising: physically or chemically modifying a montmorillonite to produce a modified montmorillonite having a relatively wide layer spacing; taking a natural cellulose to a specific The ratio is mixed or polymerized with the modified montmorillonite in an aqueous phase environment.
如申請專利範圍第7項所述的壁癌生成抑制材料之製造方法,該蒙脫土係先以一陽離子型介面活性劑將蒙脫土的表面予以改質,再將該蒙脫土與一有機改質劑聚合,形成具有擴張層間距之該改質蒙脫土。The method for producing a wall cancer production inhibiting material according to the seventh aspect of the invention, wherein the montmorillonite first modified the surface of the montmorillonite with a cationic surfactant, and then the montmorillonite and the montmorillonite The organic modifier is polymerized to form the modified montmorillonite having an expanded layer spacing.
如申請專利範圍第7或8項所述的壁癌生成抑制材料之製造方法,該陽離子型介面活性劑為十六烷基三甲基溴化銨,該有機改質劑係選自於由甲基丙烯酸甲酯、苯乙烯及其混合物或聚合物所組成的群組;該天然纖維素係選自於由纖維素、甲基纖維素、乙基纖維素、醋酸纖維素、氫氧乙基纖維素及其混和物所組成的群組。The method for producing a wall cancer production inhibiting material according to claim 7 or 8, wherein the cationic surfactant is cetyltrimethylammonium bromide, and the organic modifier is selected from the group consisting of a group consisting of methyl acrylate, styrene, and mixtures or polymers thereof; the natural cellulose is selected from the group consisting of cellulose, methyl cellulose, ethyl cellulose, cellulose acetate, and hydroxyethyl ethyl cellulose. a group of primes and their mixtures.
如申請專利範圍第9項所述的壁癌生成抑制材料之製造方法,該天然纖維素與該改質蒙脫土的混合比例範圍為9:1~1:9。The method for producing a wall cancer production inhibiting material according to claim 9, wherein the mixing ratio of the natural cellulose to the modified montmorillonite is in the range of 9:1 to 1:9.